These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3443056)

  • 41. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.
    Siewert-Delle A
    Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Value of non-drug treatment and drug treatment in hypertension.
    Beilin LJ
    Drugs; 1988; 36 Suppl 6():1-9. PubMed ID: 3077110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypertension--when is the clinical problem solved? When patients are rendered normotensive.
    Mancia G; Lanfranchi A; Cattaneo BM; Grassi G
    Cardiology; 1994; 85 Suppl 1():58-64. PubMed ID: 7743536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.
    Feldman RD; Campbell N; Larochelle P; Bolli P; Burgess ED; Carruthers SG; Floras JS; Haynes RB; Honos G; Leenen FH; Leiter LA; Logan AG; Myers MG; Spence JD; Zarnke KB
    CMAJ; 1999; 161 Suppl 12(12):S1-17. PubMed ID: 10624417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihypertensive treatment: does the J-curve exist?
    Hansson L
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):367-72. PubMed ID: 10999642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hypertension and ischemic heart disease.
    Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S12-9. PubMed ID: 2483226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ventricular arrhythmias in hypertension: in which patients do they occur?
    Mayet J; Shahi M; Poulter NR; Sever PS; Thom SA; Foale RA
    J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment.
    Endemann DH; Pu Q; De Ciuceis C; Savoia C; Virdis A; Neves MF; Touyz RM; Schiffrin EL
    Hypertension; 2004 Feb; 43(2):399-404. PubMed ID: 14707158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy.
    Hu C; Kong H; Qu F; Li Y; Yu Z; Gao P; Peng S; Xu G
    Mol Biosyst; 2011 Dec; 7(12):3271-9. PubMed ID: 22009255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in population blood pressure and determinant factors for population blood pressure.
    Andersen UO
    Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Special features of pharmacotherapy in older hypertensive subjects].
    Kreutz R
    Internist (Berl); 2009 Apr; 50(4):442-54. PubMed ID: 19300976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychiatric morbidity and hostility in hypertension.
    Mann AH
    Psychol Med; 1977 Nov; 7(4):653-9. PubMed ID: 594245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The child or adolescent with elevated blood pressure.
    Ingelfinger JR
    N Engl J Med; 2014 Sep; 371(11):1075. PubMed ID: 25207779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.